Cellular Physiology and Biochemistry Cellular Physiology and Biochemistry Original Paper Tanshinone Iia Improves Mir-133 Expression through Mapk Erk1/2 Pathway in Hypoxic Cardiac Myocytes Cellular Physiology and Biochemistry Cellular Physiology and Biochemistry
Cellular Physiology and Biochemistry Cellular Physiology and Biochemistry Original Paper Tanshinone Iia Improves Mir-133 Expression through Mapk Erk1/2 Pathway in Hypoxic Cardiac Myocytes Cellular Physiology and Biochemistry Cellular Physiology and Biochemistry
复制标题
DOI:
--
复制
发表时间:
--
期刊:
影响因子:
--
通讯作者:
H. Shan;Li Zhang;Yanli Wu;Yumei Li;Chaoqian Xu;Xuelian Li;Daling Zhu;Yan Zhang;Shu Xing;Haoyan Wang;Zhihua Zhang
中科院分区:
文献类型:
--
作者:
H. Shan;Li Zhang;Yanli Wu;Yumei Li;Chaoqian Xu;Xuelian Li;Daling Zhu;Yan Zhang;Shu Xing;Haoyan Wang;Zhihua Zhang
Tanshinone IIA is a lipid-soluble pharmacologically active compound extracted from the rhizome of Chinese herb Salvia miltiorrhiza, a well-known traditional Chinese medicine used for the treatment of cardiovascular disorders. Previous studies have identified that tanshinone IIA inhibited overexpression of miR-1 in hypoxic neonatal cardiomyocytes. This study was designed to examine the effects of tanshinone IIA on miR-133 expression under hypoxic condition. Neonatal rat cardiomyocytes were cultured in a hypoxic environment (2% O 2 +93% N 2 +5% CO 2) at 37°C for 24 hours. MTT, TUNEL assays, and Flow Cytometry (FCM) were performed to identify cell apoptosis. Western blot was used to examine the expression of ERK1/2 and miR-133 level was quantified by Real-time PCR. Our results showed that apoptosis was induced by hypoxia. Typical apoptotic cells were seen by TUNEL assay, and FCM showed an apoptosis rate of 13.32% in hypoxic group. Apoptosis rate in hypoxic cells was reduced significantly by tanshinone IIA. In addition, the expression level of miR-133 was increased in hypoxic cells and further upregulated by tanshinone IIA. The stress-activated protein kinase MAPK ERK1/2 was activated by hypoxia and further increased with tanshinone IIA treatment. The present study demonstrated that tanshinone IIA enhanced cell resistance to hypoxic insult by upregulating miR-133 expression through activating MAPK ERK1/2 in neonatal cardiomyocytes.